Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04056715 · ClinicalTrials.gov registry record
Extended ECG Monitoring in HCM Patients
A clinical trial, sponsored by iRhythm Technologies.
- Completed
- Registry status
- 250
- Enrollment target
NCT04056715 is a clinical trial that has completed, run by iRhythm Technologies. The registered enrollment target is 250 participants.
The verdict
NCT04056715 has completed, sponsored by iRhythm Technologies.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The purpose of this study is to determine, among a large cohort of 300 consecutive patients with hypertrophic cardiomyopathy, if extended ambulatory monitoring using the iRhythm Technologies, Inc. Zio XT device results in identifying a greater burden of nonsustained ventricular tachyarrhythmia (nsVT) compared to current ACCF/AHA guideline recommended 48-hour monitoring.
Interventions
- DEVICE Zio XT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-01-14 |
| Est. Completion | 2022-04-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04056715
The ClinicalTrials.gov registry entry for NCT04056715 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is iRhythm Technologies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zio XT is the first listed.
NCT04056715 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04056715 about?
NCT04056715 is a clinical study titled "Extended ECG Monitoring in HCM Patients". The purpose of this study is to determine, among a large cohort of 300 consecutive patients with hypertrophic cardiomyopathy, if extended ambulatory monitoring using the iRhythm Technologies, Inc. Zio XT device results in identifying a greater burden of nonsustained ventricular tachyarrhythmia (nsVT...
What is the current status of trial NCT04056715?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2020-01-14. Estimated completion is 2022-04-18.
What interventions are being tested in trial NCT04056715?
The interventions under investigation include: Zio XT (DEVICE).
Who is sponsoring clinical trial NCT04056715?
This trial is sponsored by iRhythm Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.